Craig Anderson's Publications

About Craig Anderson's Publications

Director, Brain Health Program, The George Institute
  • Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney

  • Blood pressure and dementia

    Neurology Date published:

  • Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

    International Journal of Stroke Date published:

  • A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)

    International Journal of Stroke Date published:

  • The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease

    CHEST Date published:

  • Disability patterns over the first year after a diagnosis of epilepsy

    Clinical Neurology and Neurosurgery Date published:

  • Stroke in China: advances and challenges in epidemiology, prevention, and management

    The Lancet Neurology Date published:

  • Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure

    Neurosurgery Date published:

  • Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study

    Journal of Human Hypertension Date published:

  • Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

    The Lancet Date published:

  • Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

    The Lancet Date published:

  • Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

    The Lancet Date published:

  • Does reducing blood pressure and cholesterol provide any HOPE for preventing cognitive decline and dementia?

    Neurology Date published:

  • Response to Letter to the Editor: New Insights and Old Questions in Acute Stroke Blood Pressure Control

    Neurocritical Care Date published:

  • The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes

    Health Research Policy and Systems Date published:

  • Correction to: Hospital organizational context and delivery of evidence-based stroke care: a cross-sectional study

    Implementation Science Date published:

  • Adopting a Patient-centered Approach in Acute Stroke Trials With Utility-weighted Modified Rankin Scale Scores.

    Date published: